Abstract: Renal carcinoid tumors are exceedingly rare tumors that have been primarily documented as case reports in the literature. In this study, we report a series of 21 renal carcinoid tumors, with emphasis on histopathologic features and clinical outcomes. Patient age ranged from 27 to 78 years (average 52 y). The majority of specimens consisted of radical nephrectomies with or without associated lymph node dissection. Nine tumors were present in the left kidney and 10 were present in the right; location was not available for 2 specimens. No anatomic region of the kidney appeared to be preferentially involved. Twenty tumors were unifocal and ranged in size from 2.6 to 17 cm (average 6.4 cm), and 1 tumor presented as 2 nodules measuring 1 and 2.8 cm. Four patients had a documented history of a horseshoe kidney. Two patients had a history of renal calculi and 1 patient had a history of urothelial carcinoma 8 years prior. Presenting symptoms and clinical findings included back or flank pain (n = 6/9), enlarging abdominal mass or fullness (n = 2/9), hematuria (n = 2/9), and anemia (n = 1/9). Twelve patients had concurrent metastases at the time of initial surgery to sites including lymph nodes (n = 11/12), liver (n = 5/12), bone (n = 1/12), and lung (n = 1/12). One additional patient developed subsequent metastases to the liver within 6 months of surgery. Examination of the specimens identified carcinoid tumor with a variety of patterns including tightly packed cords and trabeculae with minimal stroma (n = 17/21), trabecular growth with prominent stroma (n = 4/21), focal solid nests (n = 4/21), focal glandlike lumina (n = 4/21). The border between tumor and normal kidney was sharply defined in most cases (n = 16/21), although focal infiltration was noted in 5/21 cases. Extracapsular extension was documented in 11/21 (52%) cases. Calcifications were present in 5/21 cases. Mitotic activity, measured as mitoses per 10 high-power fields, ranged from 0 to 2 in most cases, with 1 case demonstrating up to 4 mitotic figures per single high-power field. Necrosis was absent in all cases. Immunostains were frequently positive for synaptophysin (n = 18/20), chromogranin (n = 13/20), Cam5.2 (n = 14/16), and vimentin (n = 12/15). CK7 was focally positive in a small subset of cases (n = 3/18) and CK20 was positive in 1 case. TTF-1 and WT-1 were negative in all cases examined. Clinical follow-up was available on 15 patients and ranged from 3 months to 11 years. One patient died of disease at 8 months after surgery and 1 patient died without disease at 11 years after surgery. Of the remaining patients, 7 patients were alive without disease and 6 patients were alive with disease. Additional metastases developed in 4 patients and included metastases to the liver and bone.
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Within the kidney, carcinoid tumors have been reported to arise most commonly in the setting of a horseshoe kidney, although the mechanisms underlying this association are unclear. 1, 2, 7, 8, [10] [11] [12] [13] 15, 19, 23 Rare cases have also been identified as arising in the background of a renal teratoma or teratoid malformation, 8, 11, 25 and also in the setting of polycystic kidney disease. 18 Molecular analysis has only been performed on a limited number of these cases. 6, 24 The clinical implications of a diagnosis of renal carcinoid tumor remain unclear. Several cases of renal carcinoid tumor have been reported to metastasize, 4, 10, 13, 14, 21 although the overall prevalence of metastatic spread has not been well documented in these tumors. In this study, we examined 21 cases of primary renal carcinoid tumors to further elucidate the clinicopathologic findings and outcomes associated with these lesions.
MATERIALS AND METHODS

Patient Specimens
A total of 21 cases of primary renal carcinoid tumor were obtained from the archives of 5 institutions, including The Mayo Clinic (n = 7), The Johns Hopkins Hospital (n = 4), Massachusetts General Hospital (n = 4), Memorial Sloan-Kettering Cancer Center (n = 4), and The Cleveland Clinic (n = 2). Specimens were archived between the years 1970 to 2006. Hematoxylin and eosin-stained slides were examined in all cases (range 1 to 27 slides; mean 6 slides). A representative block from each case, when available, was selected for immunohistochemical studies using monoclonal antibodies against Cam5.2, CK7, CK20, chromogranin, synaptophysin, vimentin, thyroid transcription factor (TTF-1), and WT-1 ( Table 1) . Immunohistochemical results were interpreted as negative, focally positive (<25% of cells positive), or positive. Clinical data, including postoperative follow-up, were obtained from the medical records or were provided by the referring pathologists or urologists.
Molecular Analysis
In 1 case, fresh tumor tissue was available for cytogenetic analysis and ultrastructural studies. Karyotyping was performed by disaggregating minced tumor in collagenase for 15 hours, and cells were cultured for 3 days. Metaphase cells were prepared and analyzed. Tissue for electron microscopy was fixed in 3% glutaraldehyde solution, postfixed in 1% osmium tetroxide, dehydrated, and embedded in epoxy resin. Thick sections were stained with methylene blue. Thin sections were stained with uranyl acetate-lead citrate and examined with a transmission electron microscope.
RESULTS
Clinical Features
Patient demographics are summarized in Table 2 . In brief, patients ranged in age from 27 to 78 years, with an average age of 52 years. Nine patients were less than 50 years of age (n = 9/20; 45%). Gender information was available on 20 patients, with 10 males (50%) and 10 females (50%). Eighteen patients underwent radical nephrectomy with lymph node dissection and 1 patient underwent partial nephrectomy; surgical procedure was unknown in 2 patients. Laterality was described as right in 10 cases (n = 10/19; 53%) and left in 9 cases (n = 9/19; 47%). The majority of patients demonstrated no additional masses clinically or radiographically, which was consistent with a primary renal tumor. In the small subset of patients with distant metastases (see below), metastases were either small or multiple in nature and associated with a sizeable renal mass.
Nine of 21 patients (43%) had documented signs or symptoms associated with the tumor, including back or flank pain (n = 6/9), hematuria (n = 2/9), enlarging abdominal mass (n = 1/9), anemia (n = 1/9), and fever (n = 1/9). Two patients had a reported history of renal calculi and 1 patient had a history of urothelial carcinoma 8 years before the diagnosis of renal carcinoid tumor. None of these patients had clinical signs or symptoms of carcinoid syndrome. No patient had a history of multiple endocrine neoplasia or other familial cancer syndrome. Of note, 4 patients had a documented history of horseshoe kidney.
Histopathologic Features
Most of the tumors were unifocal (n = 20/21), whereas only 1 case was multifocal (n = 1/21). Various regions of the kidney were involved by tumor, including the lower pole (n = 6/15), upper pole (n = 3/15), midpole (n = 2/15), and renal pelvis (n = 4/15). Tumor size ranged from 2.6 to 17 cm for unifocal tumors (average size 6.4 cm). In the multifocal case, there were 2 nodules of 1 and 2.8 cm, respectively. Pathologic tumor stage included T1a (n = 3), T1b (n = 1), T2 (n = 5), and T3a (n = 11). There were no tumors of stage T3b, T3c, or T4.
The junction between tumor and adjacent renal parenchyma was sharply defined in most cases (n = 16/ 21; 76%), although focal infiltration was identified in 5 cases. Of 19 cases in which either all slides were available for review or extrarenal extension was noted in the report, 11 cases (58%) demonstrated extension into the perirenal soft tissue or the renal pelvic fat. The predominant histologic pattern of tumor consisted of tightly packed cords and trabeculae of neoplastic cells, imparting a ribbonlike appearance (Fig. 1) , with minimal stroma (n = 17/21; 81%) ( Table 3) . Four cases demonstrated trabecular growth with prominent stroma consisting of dense fibrotic bands (n = 4/21; Fig. 2) . In 1 case, the stroma was edematous and demonstrated prominent lymphocytic infiltrates. Focal areas of solid growth with nest formation were identified in 4 cases (Fig. 3) and the formation of glandlike lumina was noted in 4 cases (Fig. 4) . The nuclei were elongated and oval, and situated with their long axis perpendicular to the long axis of the cords and trabeculae. The nuclear chromatin was finely granular and dispersed with inconspicuous nucleoli (Fig. 5) . Calcifications were present in 5 of 21 cases (24%) and varied in size from small, psammomatous calcifications to large calcified regions of tumor. One case had metaplastic bone formation. Most tumors demonstrated 0 to 2 mitoses/10 high-power fields (HPF) (n = 19/21), although a subset demonstrated up to 3 (n = 1/21) or 4 (n = 1/21) mitoses/10 HPF. None of the cases exhibited necrosis.
Ultrastructural analysis of 1 case demonstrated neurosecretory granules (Fig. 6 ) and the karyotype of the same tumor was normal.
Immunohistochemical stains were available or performed on 20 cases. Synaptophysin was the most commonly positive marker (n = 18/20; Fig. 7 ), in addition to chromogranin (n = 13/20), Cam5.2 (n = 14/16), and vimentin (n = 12/15). Focal immunoreactivity for CK7 was noted in 3/18 cases (Fig. 8) . CK20 was positive in 1 case. Finally, TTF-1 and WT-1 were negative in 17 and 15 cases examined, respectively.
Patient Outcomes
At the time of surgery, the presence or absence of metastases was documented in 13 patients, of which 12 had metastatic disease. Metastases were present in regional lymph nodes (n = 11/12), retroperitoneal lymph nodes (n = 1/12), periaortic lymph nodes (n = 1/12), liver (5/12), bone (n = 1/12), and lung (n = 1/12). Seven patients underwent subsequent additional treatment, including postoperative external beam radiation (n = 1/7), radioablation of liver metastases (n = 1/7), and systemic treatment (n = 5/7) consisting of various regimens including doxetaxol, capecitabine, 5-fluorouracil, carboplatin, and temozolomide. Extended clinical follow-up was available on 15 of 21 patients (71%) and ranged from 3 months to 11 years (mean 37 mo, median 36 mo). In addition to the 12 patients with metastases at the time of surgery, an additional patient developed liver metastases within 6 months of surgery, resulting in a total of 62% of patients developing metastatic disease at or near the time of initial diagnosis. Of patients with existing metastases, new metastases developed to the liver and bone in 4 patients.
Only 1 patient who demonstrated both liver and bone metastases at initial diagnosis was dead of disease at 8 months after the surgery. Of the remaining patients with follow-up, 7 patients were alive without disease (n = 7/15) and 6 patients were alive with disease (n = 6/15). One patient died without disease from other causes 11 years after diagnosis with renal carcinoid tumor. Of the 10 cases with documented lymph node metastases at initial surgery, 3 patients with only regional lymph node metastases were alive without disease at 3, 5, and 5 years, respectively. The remaining patients with metastatic disease, either to nonregional lymph nodes or to distant FIGURE 6 . Ultrastructural analysis performed on 1 tumor demonstrates the presence of neurosecretory granules (arrow). sites, were alive with disease at time periods ranging from 1 to 4 years.
DISCUSSION
Primary renal carcinoid tumor is an exceedingly rare neoplasm and, to date, most studies in the literature have been case reports or small case series. 9, 14, 16, 17, 20, 23 Previous reports have also documented the development of metastatic disease in several patients with renal carcinoid tumor, and 1 study has correlated poor patient outcomes with increased mitotic activity and cytologic atypia within the renal carcinoid tumor.
14 This study has examined 21 cases of renal carcinoid tumor to further delineate histopathologic findings and clinical outcomes in these patients.
The patients in our study were approximately evenly divided between male and female patients. Renal carcinoid tumor appeared to present at a younger age than renal cell carcinoma, with many patients in our study presenting below 50 years of age. Four patients had a horseshoe kidney from which the renal carcinoid appeared to arise. 1 Although the majority of patients in our study were diagnosed with either local or distant metastatic disease at the time of initial diagnosis, most patients were asymptomatic and tumors were discovered incidentally on workup for other conditions. Despite the high rate of metastases, only 1 patient died of disease, whereas the remaining patients demonstrated prolonged survival. No specific chemotherapeutic regimen demonstrated outcome benefits in the subset of patients who received treatment. Approximately half of all cases demonstrated extension into the perirenal or pelvic fat.
Renal carcinoid tumor demonstrated the characteristic appearance of carcinoid tumors seen elsewhere. Although most of the cases demonstrated similar mitotic rates, ranging from 0 to 3/10 HPF, the one case that demonstrated the highest mitotic rate (4 mitoses/10 HPF) belonged to the patient who died of disease at 8 months. None of our cases would qualify for the diagnosis of ''atypical carcinoid tumor,'' as defined in the lung, as the renal carcinoid tumors demonstrated an overall low mitotic rate and lack of necrosis.
Immunohistochemical stains were consistent with the diagnosis of carcinoid tumor, with the majority of cases demonstrating strong immunoreactivity for synaptophysin, chromogranin, Cam5.2, and vimentin. A small number of cases were focally positive for CK7 and CK20. TTF-1 and WT-1 were negative in all cases examined, thereby ruling out a lung metastasis or adult Wilms tumor, respectively. In addition, the neuroendocrine phenotype was supported by the presence of neurosecretory granules on ultrastructural analysis in 1 case.
Data regarding cytogenetics in renal carcinoid is limited. Two previous reports have documented a loss of heterozygosity at the D3F15S2 locus of 3p21 in 1 case 6 and 47,XX+13 [8] /46,XX,t(13;14)(q31;q11.2) [5] /46, XX [2] in a second case arising in a horseshoe kidney. In contrast, the single case examined in our series demonstrated a normal karyotype.
Most renal carcinoids, as with carcinoid tumors elsewhere, are quite characteristic in their morphologic appearance. The differential diagnosis of renal carcinoid tumor includes other tumors with neuroendocrine features, including small cell carcinoma, primitive neuroectodermal tumor (PNET), paraganglioma, and neuroblastoma. In contrast to small cell carcinoma, renal carcinoid tumors lack a brisk mitotic rate, apoptotic activity, and cellular molding. Furthermore, most small cell carcinomas lack the typical organized architecture that is distinctive for the carcinoid tumor. 3, 22 PNET can occur over a wide age spectrum and generally demonstrates a monotonous cellular population containing bland, rounded nuclei with variable mitotic activity. Both PNET and renal carcinoid tumor can demonstrate solid areas and regions of rosettelike structures, although unlike renal carcinoids, PNET is strongly positive for CD99. Paragangliomas and intrarenal neuroblastomas are exceedingly rare, although both can mimic renal carcinoid. Paragangliomas more commonly contain a nested pattern of neuroendocrine cells with granular basophilic cytoplasm surrounded by S100 positive sustentacular cells. Neuroblastomas, in contrast to renal carcinoid tumor, contain a background of neurofibrillary stroma and demonstrates Homer-Wright rosettes.
In conclusion, this study presents the largest collection of primary renal carcinoid tumors to date. This neoplasm often occurs in patients younger than 50 years of age, affects male and female patients with equal frequency, and does not appear to present with carcinoid syndrome. Morphologically, renal carcinoid tumor is consistent with carcinoid tumors present at other anatomic sites. Patients frequently present with regional lymph node metastases and may progress to distant organ metastases, but usually have a prolonged clinical course despite widely metastatic disease.
